AmSurg shares receive ‘strong-buy’ rating — 6 notes

Zacks gave AmSurg shares a “strong-buy” rating, according to The Legacy.

Advertisement

Here are six notes:

1. AmSurg presently has a price target of $95.00.

2. AmSurg surpassed Zacks’ consensus estimate because of the company’s focus on organic growth and acquisition strategies.

3. AmSurg stock opened at $82.44 on Thursday, Aug. 6.

4. The company has a market cap of $3.93 billon and a P/E ration of 71.19.

5. AmSurg’s 50-day moving average price is $71.54 and its 200-day moving price is $64.80.

6. The company has a one-year low of $47.68 and a one-year high of $85.52.

More on surgery centers:
Barclay analysts raise SCA price target to $45 — 5 notes
Revere Health to break ground on new facility, surgery center
28 ASC joint ventures & acquisitions in 2015 so far

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.